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Dear Editor,
There is increasing awareness of an on-going epidemicof sexually-transmitted acute hepatitis C virus (HCV)
infection among HIV-infected men who have sex with men
(MSM). The percentage of all HIV infected people who also
have HCV ranges from 15% to 30%, and one study reported
that 37% of people with HIV were co-infected with HCV.1,2
Unrecognized HIV/HCV co-infection has serious implica-
tions on liver health, as it may accelerate the progression of
HCV liver disease.1,2 Early detection of people co-infected with
HIV and HCV is essential in managing treatment of these
infections. Thus in 2009, the European Aids Clinical Society
(EACS) guidelines3 introduced the notion of systematic annual
HCV screening among HIV-infected patients. All HIV-infected
patients should be screened for HCV infection using sensitive
immunoassays licensed for detection of antibody to HCV in
blood.2 HCV-seronegative patients at risk for acquiring HCV
infection should undergo repeat testing annually.
We evaluated, retrospectively, staff knowledge, HCV
screening rates, and seroconversion rates for HCV of indi-
viduals enrolled in our AIDS Reference Centre in order to
determine physicians’ adherence to HCV-screening recom-
mendations. This study was designed on a criterion-based
medical audit framework, with annual HCV serology in non-
immune as the selected standard, and all HIV patients as a
target. Eight physicians (HIV specialists) were interviewed on
recommendations and perceived adherence to EACS clinical
guidelines regarding HCV screening. Self-reported knowl-
edge and adherence were assessed through face-to-face in-
terviews with each of the physicians.
Patients on regular follow-up each year from 2008 to 2011
in the Centre were included. We considered a patient to be on
regular follow-up when records showed at least two clinical
reviews and one HIV viral load testing during the year. De-
mographic features and HCV serology tests were collected
from the operating software of our institution.
Adherence to guidelines was measured by dividing the
percentage of the patient population receiving the service
(HCV screening) by the percentage of the patient population
who should have received the service according to the
guidelines, in this case, the whole HIV-positive population on
follow-up. Diagnosis of HCV was retained when serology
became positive and HCV RNA was detected. Percentage of
patients screened were compared using the X2 test, and a two-
tailed p< 0.05 was considered statistically significant.
Though knowledge of current guidelines was excellent
(100%), physicians claimed an 87.5% (7/8) adherence rate to
these recommendations. The objective rate of screening rose
gradually between 2008 and 2011, especially after introduc-
tion of EACS guidelines in 2009 (Table 1 and Fig. 1). The
maximal screening rate was obtained in 2011, with 44% of
patients tested among the general HIV population and 57%
among MSM–bisexual patients. This trend was statistically
significant in both populations ( p< 0.01). Additional analyses
on screening rates were done according to risk factors. No
active intravenous drug user was observed among our pa-
tients from 2007 to 2011. In our cohort, MSM were signifi-
cantly more tested than heterosexual patients (X2, p< 0.0001).
The year 2011 displayed a marked increase in diagnosis of
HCV infection, with 8 new patients diagnosed among the 963
patients who met inclusion criteria; all of them were MSM.
Clinical guidelines are increasingly being used to improve
the quality of medical care. An important task in guideline-
based quality improvement, the assessment of medical care
quality, can be accomplished by retrospectively comparing
clinician actions to the guideline recommendations. Perfor-
mance measures are defined as ratios that determine the ex-
tent to which a clinician’s action conform to the clinical
practice guideline. However, it is still mostly limited to eval-
uating simple one-step elements of medical care.4 Literature
on adherence to guidelines relies partly on self-reporting.
Validity of such literature is questionable, as there is a possible
response bias in self-report. When compared to more objec-
tive measures, Adams et al. confirmed the existence of a
substantial overestimation of adherence (median absolute
difference of 27%).5 Our team was no exception to this, with
an absolute difference of 29.5% at best.
Though not many studies address the issue of adherence to
preventive measures recommendations among HIV special-
ists, results show very variable rates of compliance. On the
specific issues of hepatitis B or C screening, mostly studies
addressing initial screening could be found. Our figures are
consistent with those of Hoover et al., who evaluated
screening rates for hepatitis B and C in a random sample of
HIV-infected MSM in HIV clinics in the US to 52% and 54%,
respectively.6 However, looking at the British national audit
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on co-infections, annual screening rates for HBV and HCV
were 71% and 66%, respectively, though these figures rely on
self-reported estimates.7 Among US veterans tested for HIV
and found to be positive for HIV, Wright et al. observed that
approximately 79.1% were co-tested for HCV.8 On the other
hand, HIV screening in HCV-positive patients among the
Veterans Health Administration, Fuller et al. demonstrated
that only approximately one-third of veterans with HCV were
tested for HIV (32%).9 The ECDC review on hepatitis B and C
collected available data in several specific populations.
Among IDUs for example, the proportion of patients screened
for HCV varied between 5% in the United Kingdom and 88%
in Ireland.10 These results, though quite variable, tend to
demonstrate a trend towards low adherence to hepatitis
screening guidelines. They underscore the need for providers
and clinics to evaluate their data and implement effective and
sustainable interventions to increase hepatitis screening.
In recent years, there have been reports of HCV infection
acquisition in HIV-infected MSM linked to sexual transmis-
sion and associated with the use of nonparenteral recreational
drugs.2,11 This was translated in previous guidelines as re-
commended annual HCV screening in HIV patients with se-
lected risk factors. It probably explains the higher rates of
screening among the MSM–bisexual population in our cohort.
Garvey et al. suggested that reasons for suboptimal screening
rates may include a clinical decision that a subject is at ‘low
risk’, for example to HCV, thus making the test a low priority
and other general time constraints in the outpatient setting.7
These seemed relevant in our centre, where only a third of
the patients are MSM, and no active IDU is currently on
follow-up. Qualitative research would be useful in identifying
barriers to better adherence and in selecting appropriate in-
terventions to improve quality of care.
Bonnard et al. already implemented a tool (ORCHESTRA
Programme: automatic remind to test HCV) on an active
cohort of 3000 HIV-infected patients. One year after im-
plementing this system, the proportion of HIV-infected
patients whose last negative HCV screening test dated
back more than 3 years fell from 46% to 24%, however,
these measures failed to increase HBV and HAV vaccine
uptake.12
In our Centre, knowledge of EACS guidelines on screening
for HCV was good but adherence to these recommendations
is poor, though it improves over time. Education of clinicians
is warranted to increase awareness and further improve ad-
herence to guidelines. Qualitative research might help in
identifying barriers and in selecting appropriate interventions
to improve quality of care.
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